Skip to content

Search for:

New to Type 1 Diabetes

Living with Diabetes

Conferences & Community

News

About CWD

New to Type 1 Diabetes
Living with Diabetes
Conferences & Community
CWD Answers
News
About CWD
Donate to CWD
Search for:

Archives

Research News

advertisement

April 21, 2010

A bihormonal closed-loop artificial pancreas for type 1 diabetes. See also Novel Artificial Pancreas System Using Two Hormones Successfully Controls Blood Sugar Levels In Type 1 Diabetes Patients and Research offers promise for diabetics. To learn more, see Using mathematics to treat diabetes … five minutes at a time (specifically the Publications section).
Infant feeding and the risk of type 1 diabetes.
Monocyte Gene-Expression Profiles Associated With Childhood-Onset Type 1 Diabetes and Disease Risk: A Study of Identical Twins.
Quantification and 3-D imaging of the insulitis-induced destruction of beta-cells in murine Type 1 Diabetes.
Skin fluorescence correlates strongly with coronary artery calcification severity in type 1 diabetes.
Real-life glycaemic profiles in non-diabetic individuals with low fasting glucose and normal HbA(1c): the A1C-Derived Average Glucose (ADAG) study.

April 14, 2010

Suspended insulin infusion during overnight closed-loop glucose control in children and adolescents with Type 1 diabetes.
Maternal intake of vitamin D during pregnancy and risk of advanced beta cell autoimmunity and type 1 diabetes in offspring.
Inflammatory Markers Are Increased in Youth with Type 1 Diabetes: The SEARCH Case-Control Study.
Insulin Resistance is Associated with Microangiopathy in Type 1 Diabetic Patients Treated with Intensive Insulin Therapy from the Onset of Disease.
HLA-DR genotypes influence age at disease onset in children and juveniles with type 1 diabetes mellitus.
Incidence trends of childhood type 1 diabetes in eastern Saudi Arabia.

April 7, 2010

C-Peptide as a Therapeutic Tool in Diabetic Nephropathy.
Cardiovascular autonomic neuropathy and other complications in type 1 diabetes.
No Effect of the 1-alpha,25-dihydroxyvitamin D3 on Beta Cell Residual Function and Insulin Requirement in Adults with New-Onset Type 1 Diabetes.
Dietary intake of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and diabetic nephropathy � cohort analysis of the Diabetes Control and Complications Trial (DCCT).

March 31, 2010

In light of the suggested correlation between vitamin D deficiency and increased risk for type 1 diabetes, Adherence to Vitamin D Recommendations Among US Infants and Widespread Vitamin D Deficiency in Urban Massachusetts Newborns and Their Mothers are noteworthy.
Infant feeding and the risk of type 1 diabetes.
Type 1 diabetes patients born to immigrants to Sweden increase their native diabetes risk and differ from Swedish patients in HLA types and islet autoantibodies.
Lack of effect of short-term treatment with Amlodipine and Lisinopril on retinal autoregulation in normotensive patients with type 1 diabetes and mild diabetic retinopathy.
Leptin therapy in insulin-deficient type I diabetes. Free full text available in HTML and PDF formats. See also Texas Researcher Poised to Test Leptin as a Replacement for Insulin Among Type 1s.

March 24, 2010

Novel Use of Glucagon in a Closed-Loop System for Prevention of Hypoglycemia in Type 1 Diabetes.
Vitamin D and Diabetes.
Alterations in Retinal Microvascular Geometry in Young Type 1 Diabetes.
High-Normal Serum Uric Acid Increases Risk of Early Declining Renal Function In Type 1 Diabetes: Results of 6-year Follow-up.
Do statins delay the incidence of ESRD in diabetic patients with moderate CKD?

March 17, 2010

Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass.
Continuous Glucose Monitoring Reveals Associations of Glucose Levels with QT Interval Length.
Successes and disappointments with clinical islet transplantation.
The Programmable Cell of Monocytic Origin (PCMO): A Potential Adult Stem/Progenitor Cell Source for the Generation of Islet Cells.
The Type 1 Diabetes – HLA Susceptibility Interactome – Identification of HLA Genotype-Specific Disease Genes for Type 1 Diabetes. Free full text available in HTML and PDF formats (see HTML full text for PDF link).
Experimental extracorporeal photopheresis therapy significantly delays the development of diabetes in non-obese diabetic mice.

March 10, 2010

Association of A1c Levels with Vitamin D Status in U.S. Adults: Data from the National Health and Nutrition Examination Survey.
Feature Article: Leptin therapy in insulin-deficient type I diabetes.
Treatment with insulin glargine (Lantus((R))) increases the proliferative potency of the serum of patients with type-1 diabetes: a pilot study on MCF-7 breast cancer cells.

March 3, 2010

Effects of ghrelin, growth hormone-releasing peptide-6, and growth hormone-releasing hormone on growth hormone, adrenocorticotropic hormone, and cortisol release in type 1 diabetes mellitus.
Adiponectin, total antioxidant status, and urine albumin excretion in the low-risk “Golden Years” type 1 diabetes mellitus cohort.
Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes.

February 24, 2010

Immunomodulation with microbial vaccines to prevent type 1 diabetes mellitus.
Immune therapy for type 1 diabetes mellitus-what is unique about anti-CD3 antibodies?
Stem cell therapy for type 1 diabetes mellitus.
Amperometric Glucose Sensors: Sources of Error and Potential Benefit of Redundancy.
Simulation Environment to Evaluate Closed-Loop Insulin Delivery Systems in Type 1 Diabetes.
Effectiveness of Intravenous Infusion Algorithms for Glucose Control in Diabetic Patients Using Different Simulation Models.
Clinical Evaluation of a Noninvasive Alarm System for Nocturnal Hypoglycemia.

February 17, 2010

MD-Logic Artificial Pancreas System: A Pilot Study in Adults with Type 1 Diabetes Mellitus.
Carotid intima-media thickness and its relations with the complications in patients with type 1 diabetes mellitus.
Exploring self-management characteristics in youths with type 1 diabetes mellitus: does membership in a glycemic control category matter?
The impact of vitamin D deficiency on diabetes and cardiovascular risk.

« Previous
1
…
65
66
67
68
69
…
94
Next »

advertisement

Last Updated: Wednesday, June 18, 2025 02:32:36 UTC

This internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

Terms of Use

About Us

Contact Us
- Contact Us
- Submit a Question

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes, EIN #46-3704802), a 501c3 not-for-profit organization, which is responsible for its contents. By using this site, you agree to our Terms of Use, Legal Notice and Privacy Policy.

Children with Diabetes.com © 1995-2025 | Comments and Feedback | All Rights Reserved.

Social

Four-Star Rating Badge - Full Color

DK Popup

This is a popup.

Submit Your Story

If you’d like your story to be considered for inclusion on our website, please fill out the form below.

Name*
First Last
Email*
Enter Email Confirm Email
Address
State / Province / Region Country

Please let us know about where you live.
Date of Birth*
Month
Day
Year
We ask for your birth date so that we can limit what is used on the website if you are under 18.
Date Diagnosed
Month
Day
Year
If you don't know the exact day, don't worry. Just choose the correct month and/or correct year and note this in your story.
Your Story*
Please tell us about yourself and your connection to diabetes.
Your Photo
Accepted file types: jpg, jpeg, png, Max. file size: 25 MB.
If you have a photo, upload it here.
Short Bio
Please include a short bio of yourself so we can consider it for inclusion with the story. This will appear underneath your photo.
Consent to Use My Story and Photo*
I agree with terms below.
By submitting my information, photo, and/or video, I give Children with Diabetes permission to use my story, imagery, photograph(s), and/or video(s), in its promotional materials and publicity efforts. I understand that the imagery may be used in, but not limited to, a publication, print ad, direct-mail piece, electronic media, or other form or promotion; and that my name and additional information collected by the organization may be used in conjunction with the image(s). I release Children with Diabetes from liability for any violation of any personal or proprietary right I may have in connection with such use.

Contact Us

Help Us Understand You Better.

Please answer a few questions to help us understand how best to serve you. You are not required to answer, but we hope you will. This information will be collated and may be published on our website periodically, or may be used for publication, but we will use composite data only. We do not maintain any individual data from these items. If you ask another question at a later time, please fill this out each time.

This form is just for questions related to diabetes care. If you have questions about anything else related to Children with Diabetes, please use our Contact Us form.
This question is on behalf of:
The question applies to this age group:
This question relates to:
We've had diabetes for:
We use this treatment for diabetes:
We have the following insurance:
We receive diabetes care from:
I'm asking this question because:
Type in Your Question Here.
What is your email address?
If you would like to have the answer emailed to you, please include your email address.
Where do you live?
Please tell us where you live (city, state, and country). This information can help us answer your question.
What is your question?*
To preserve confidentiality, we strongly recommend that you do not include in your question any information that identifies you, your child, or any other individual. Please note: questions that are published may be edited for space and clarity.
Phone
This field is for validation purposes and should be left unchanged.

First Name*
Last Name*
Email*
What is your connection to type 1 diabetes?*
- I have type 1 diabetes
- I have a child with type 1 diabetes
- I have type 1 and have a child with type 1
- I am a health care professional
- Other
Phone
This field is for validation purposes and should be left unchanged.